Valuation genOway

Stocks

Market Closed - Euronext Paris 09:25:00 07/09/2026 pm IST			5-day change	1st Jan Change
2.480 ^EUR	0.00%		0.00%	-8.49%

30/03	GenOway Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
31/12	GenOway Société anonyme completed the acquisition of Data Science and AI assets in OMICS platform.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	21.45	37.85	35.3	40.59	34.58	24.99
Change	-	76.49%	-6.76%	15%	-14.82%	-27.73%
Enterprise Value (EV) ¹	29.49	43.07	39.45	43.56	35.2	31.7
Change	-	46.05%	-8.41%	10.42%	-19.2%	-9.93%
P/E	-	-	-	-	-	-
PBR	-	-	-	-	-	-
PEG	-	-	-	-	-	-
Capitalization / Revenue	1.32x	1.93x	1.67x	1.53x	1.26x	0.87x
EV / Revenue	1.81x	2.2x	1.87x	1.64x	1.28x	1.11x
EV / EBITDA	34.9x	99.8x	13.1x	7.49x	9.04x	7.16x
EV / EBIT	-78.2x	-54.6x	80.7x	27.8x	27x	24.9x
EV / FCF	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-
Distribution rate	-	-	-	-	-	-
Net sales ¹	16.29	19.59	21.09	26.51	27.53	28.6
EBITDA ¹	0.844	0.4318	3.006	5.815	3.894	4.428
EBIT ¹	-0.3771	-0.7893	0.4886	1.565	1.304	1.274
Net income ¹	-0.6873	-0.3226	0.7778	1.568	1.831	0.9278
Net Debt ¹	8.045	5.22	4.156	2.973	0.623	6.718
Reference price ²	3.100	4.290	4.000	4.600	3.750	2.710
Nbr of stocks (in thousands)	6,919	8,824	8,824	8,824	9,220	9,220
Announcement Date	28/04/22	28/04/22	28/04/23	01/05/24	29/04/25	30/04/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENOWAY	-	-	-	-	2.66Cr
LONZA GROUP AG	33.15x	5.95x	17.82x	0.98%	4.89TCr
REVOLUTION MEDICINES, INC.	-21.5x	245.64x	-23.19x	-.--%	4.5TCr
IQVIA HOLDINGS INC.	34.48x	3.33x	14.35x	-.--%	4.41TCr
BEONE MEDICINES AG	46.93x	5.41x	29.72x	-.--%	4.07TCr
CELLTRION, INC.	28.42x	8.6x	21.8x	0.4%	3.35TCr
MEDPACE HOLDINGS, INC.	33.62x	5.51x	25.02x	-.--%	1.65TCr
EUROFINS SCIENTIFIC SE	24.24x	2.11x	9.11x	1.11%	1.47TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.18x	4.06x	15.75x	-.--%	1.38TCr
Average	32.07x	35.07x	13.80x	0.31%	2.86TCr
Weighted average by Cap.	27.26x	47.36x	12.31x	0.3%